Aug 8, 2025 09:48AM
Aug 8, 2025 06:35AM
Aug 7, 2025 07:30AM
Aug 5, 2025 08:30AM
Aug 5, 2025 08:30AM
May 13, 2025 06:35AM
Mar 4, 2025 06:35AM Y-mAbs Reports Fourth Quarter 2024 Financial Results and Recent Corporate Developments
Jan 10, 2025 09:26AM
Jan 10, 2025 07:10AM
Jan 10, 2025 07:05AM
Nov 8, 2024 06:38AM
Nov 8, 2024 06:35AM
Aug 12, 2024 06:33AM
Aug 12, 2024 06:30AM Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
May 7, 2024 04:41PM
May 7, 2024 04:05PM
Apr 26, 2024 07:05AM
Mar 4, 2024 08:14AM
Feb 29, 2024 04:30PM
Feb 16, 2024 07:30AM
Nov 13, 2023 04:10PM Y-mAbs Therapeutics (YMAB) Tops Q3 EPS by 1c
Nov 13, 2023 04:05PM
Oct 31, 2023 07:05AM
Aug 10, 2023 04:07PM
Aug 10, 2023 04:05PM
Aug 1, 2023 04:05PM
May 8, 2023 05:08PM
May 8, 2023 04:01PM Y-mAbs Reports First Quarter 2023 Financial Results and Recent Corporate Developments and Updates 2023 Financial Guidance
Apr 28, 2023 09:00AM
Mar 30, 2023 05:47PM
Mar 30, 2023 04:04PM
Mar 30, 2023 04:01PM
Mar 21, 2023 04:01PM
Mar 6, 2023 09:00PM
Mar 1, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Y-mAbs, Bioventus, ESS, and IBM and Encourages Investors to Contact the Firm
Feb 24, 2023 09:00PM
Feb 19, 2023 09:00PM
Feb 13, 2023 09:00PM
Feb 8, 2023 09:00PM
Feb 3, 2023 09:00PM
Jan 29, 2023 09:00PM
Jan 23, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioLineRx, Enovix, Southwest Airlines, and Y-mAbs and Encourages Investors to Contact the Firm
Jan 4, 2023 04:02PM
Jan 4, 2023 04:01PM
Nov 7, 2022 04:01PM
Nov 2, 2022 04:01PM
Oct 31, 2022 01:58PM
Aug 8, 2022 04:44PM
Aug 8, 2022 04:05PM Y-mAbs Announces Second Quarter Financial Results and Recent Corporate Developments
Aug 2, 2022 09:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All